PREMARIN Drug Patent Profile

✉ Email this page to a colleague

When do Premarin patents expire, and when can generic versions of Premarin launch?

Premarin is a drug marketed by Wyeth Pharms and is included in three NDAs.

The generic ingredient in PREMARIN is estrogens, conjugated. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the estrogens, conjugated profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PREMARIN?
What are the global sales for PREMARIN?
What is Average Wholesale Price for PREMARIN?

Summary for PREMARIN

US Patents:	0
Applicants:	1
NDAs:	3
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	31
Clinical Trials:	52
Patent Applications:	3,702
Drug Prices:	Drug price information for PREMARIN
Drug Sales Revenues:	Drug sales revenues for PREMARIN
What excipients (inactive ingredients) are in PREMARIN?	PREMARIN excipients list
DailyMed Link:	PREMARIN at DailyMed

Drug patent expirations by year for PREMARIN

Recent Clinical Trials for PREMARIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mackay Memorial Hospital	Phase 4
Carol Fabian, MD	Early Phase 1
University of Louisville	Phase 4

See all PREMARIN clinical trials

Pharmacology for PREMARIN

Drug Class	Estrogen
Mechanism of Action	Estrogen Receptor Agonists

US Patents and Regulatory Information for PREMARIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms	PREMARIN	estrogens, conjugated	CREAM;TOPICAL, VAGINAL	020216-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-006	Jul 16, 2003		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	INJECTABLE;INJECTION	010402-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-003	Approved Prior to Jan 1, 1982		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-005	Jan 26, 1984		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PREMARIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms	PREMARIN	estrogens, conjugated	CREAM;TOPICAL, VAGINAL	020216-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-005	Jan 26, 1984	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	TABLET;ORAL	004782-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	PREMARIN	estrogens, conjugated	INJECTABLE;INJECTION	010402-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PREMARIN

See the table below for patents covering PREMARIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Germany	69322497		⤷ Sign Up
Canada	2089707		⤷ Sign Up
Australia	3726093		⤷ Sign Up
Australia	711571		⤷ Sign Up
Argentina	042345	UN PROCEDIMIENTO PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE ATEROSCLEROSIS QUE CONTIENE 8.9 - DEHIDROESTERONA O SUS SALES DE LA MISMA	⤷ Sign Up
Spain	2274555		⤷ Sign Up
Austria	174342		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PREMARIN

Recent Clinical Trials for PREMARIN

Pharmacology for PREMARIN

Make Better Decisions: Try a trial or see plans & pricing